BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li N, Spetz MR, Ho M. The Role of Glypicans in Cancer Progression and Therapy. J Histochem Cytochem 2020;68:841-62. [PMID: 32623934 DOI: 10.1369/0022155420933709] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Marques C, Poças J, Gomes C, Faria-Ramos I, Reis CA, Vivès RR, Magalhães A. Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates Heparan Sulfate biosynthesis and shapes gastric cancer cell motility and invasion. J Biol Chem 2022;:102546. [PMID: 36181793 DOI: 10.1016/j.jbc.2022.102546] [Reference Citation Analysis]
2 Li G, Chen W, Mi D, Wang B, Li H, Wu G, Ding P, Liang J, Zhou Z. A highly sensitive strategy for glypican-3 detection based on aptamer/gold carbon dots/magnetic graphene oxide nanosheets as fluorescent biosensor. Anal Bioanal Chem 2022. [PMID: 35788872 DOI: 10.1007/s00216-022-04201-5] [Reference Citation Analysis]
3 Shin HG, Yang HR, Yoon A, Lee S. Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy. Int J Mol Sci 2022;23:5686. [PMID: 35628495 DOI: 10.3390/ijms23105686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Lin J, Chen S, Xiao L, Wang Z, Lin Y, Xu S. Identifying Molecular Subtypes and 6-Gene Prognostic Signature Based on Hypoxia for Optimizing Targeted Therapies in Non-Small Cell Lung Cancer. IJGM 2022;Volume 15:4417-32. [DOI: 10.2147/ijgm.s352238] [Reference Citation Analysis]
5 Lin L, He Y, Ni Z, Zhang M, Liu J, Mao Q, Huang B, Lin J. GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma. Open Medicine 2022;17:304-16. [DOI: 10.1515/med-2022-0421] [Reference Citation Analysis]
6 Pham SH, Pratt K, Okolicsanyi RK, Oikari LE, Yu C, Peall IW, Arif KT, Chalmers T, Gyimesi M, Griffiths LR, Haupt LM. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers. Biochimie 2022. [DOI: 10.1016/j.biochi.2022.01.014] [Reference Citation Analysis]
7 Ghosh S, Huda P, Fletcher N, Campbell D, Thurecht KJ, Walsh B. Clinical development of an anti-GPC-1 antibody for the treatment of cancer. Expert Opinion on Biological Therapy. [DOI: 10.1080/14712598.2022.2033204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Desai SS, K RR, Jain A, Bawa PS, Dutta P, Atre G, Subhash A, Rao VUS, J S, Srinivasan S, Choudhary B. Multidimensional Mutational Profiling of the Indian HNSCC Sub-Population Provides IRAK1, a Novel Driver Gene and Potential Druggable Target. Front Oncol 2021;11:723162. [PMID: 34796107 DOI: 10.3389/fonc.2021.723162] [Reference Citation Analysis]
9 Pan J, Ho M. Role of glypican-1 in regulating multiple cellular signaling pathways. Am J Physiol Cell Physiol 2021;321:C846-58. [PMID: 34550795 DOI: 10.1152/ajpcell.00290.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ionkina AA, Balderrama-Gutierrez G, Ibanez KJ, Phan SHD, Cortez AN, Mortazavi A, Prescher JA. Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer. Breast Cancer Res 2021;23:93. [PMID: 34579762 DOI: 10.1186/s13058-021-01468-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Alshammari FOFO, Al-Saraireh YM, Youssef AMM, Al-Sarayra YM, Alrawashdeh HM. Glypican-1 Overexpression in Different Types of Breast Cancers. Onco Targets Ther 2021;14:4309-18. [PMID: 34366675 DOI: 10.2147/OTT.S315200] [Reference Citation Analysis]
12 Caravà E, Moretto P, Caon I, Parnigoni A, Passi A, Karousou E, Vigetti D, Canino J, Canobbio I, Viola M. HA and HS Changes in Endothelial Inflammatory Activation. Biomolecules 2021;11:809. [PMID: 34072476 DOI: 10.3390/biom11060809] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Paiardi G, Milanesi M, Wade RC, D'Ursi P, Rusnati M. A Bittersweet Computational Journey among Glycosaminoglycans. Biomolecules 2021;11:739. [PMID: 34063530 DOI: 10.3390/biom11050739] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
14 Li N, Spetz MR, Li D, Ho M. Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3. Pharmacol Ther 2021;223:107892. [PMID: 33992682 DOI: 10.1016/j.pharmthera.2021.107892] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Wang JY, Wang XK, Zhu GZ, Zhou X, Yao J, Ma XP, Wang B, Peng T. Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma. BMC Cancer 2021;21:462. [PMID: 33902495 DOI: 10.1186/s12885-021-08104-z] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Faria-Ramos I, Poças J, Marques C, Santos-Antunes J, Macedo G, Reis CA, Magalhães A. Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management. Biomolecules 2021;11:136. [PMID: 33494442 DOI: 10.3390/biom11020136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
17 De Pasquale V, Pavone LM. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment. Int J Mol Sci 2020;21:E6588. [PMID: 32916872 DOI: 10.3390/ijms21186588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]